Laura de Girolamo, PhD, received her MSc in Biology and PhD from the University of Milan. She got her post-doctoral training between the Galeazzi Orthopaedic Institute and other international centers. She is currently the Director of the Orthopaedic Biotechnology Laboratory of the Galeazzi Orthopaedic Institute in Milan and of the platform RE.GA.IN® (Regenerative Galeazzi Institute). The goal of Dr. de Girolamo’s laboratory is to derive biological solutions aimed to promote cartilage, tendon and bone regeneration by improving activity and clinical therapeutic potential of MSCs. She served as PI or co-PI in several research projects collaborating with national and international research centers. She is author of more than 170 peer-reviewed papers and 10 book chapters in orthopedics and regenerative medicine. She has been invited speaker at several national and international congresses and courses. She is currently co-leading the European Society of Sports Traumatology Knee Surgery and Arthroscopy (ESSKA) Orthobiologics Initiative as well as she is serving as Board Member of the same Society. From 2016 she is Chairwoman of the Research Committee of Italian Knee Surgery Arthroscopy Sports and Cartilage Society (SIAGASCOT). She is co-founder of the Italian Mesenchymal Stem Cell Group (GISM) and currently member of the Executive Committee. She is a member of the Editorial Board of Knee Surgery, Sports Traumatology, Arthroscopy (KSSTA).
|Lipogems||Scientific paid consultancy|
|Italian Mesenchymal Stem Cell Group (GISM)||Executive Board Member|
|Italian Society of Knee Arthroscopy Sport Cartilage and Orthopaedic Technology